Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies.

[1]  S. Hernández-Díaz,et al.  Trends and predictors of folic acid awareness and periconceptional use in pregnant women. , 2011, American journal of obstetrics and gynecology.

[2]  I. Rosenberg,et al.  A Temporal Association between Folic Acid Fortification and an Increase in Colorectal Cancer Rates May Be Illuminating Important Biological Principles: A Hypothesis , 2007, Cancer Epidemiology Biomarkers & Prevention.

[3]  N. Wald,et al.  Should folic acid fortification be mandatory? No , 2007, BMJ : British Medical Journal.

[4]  G. Koren,et al.  Prenatal Multivitamin Supplementation and Rates of Pediatric Cancers: A Meta‐Analysis , 2007, Clinical pharmacology and therapeutics.

[5]  Eric J Feuer,et al.  The decrease in breast-cancer incidence in 2003 in the United States. , 2007, The New England journal of medicine.

[6]  Sonya G. Oppenheimer.  Neural Tube Defects , 2007 .

[7]  A. Miller,et al.  Dietary folate consumption and risk of ovarian cancer: a prospective cohort study , 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[8]  G. Koren,et al.  Compliance with prenatal vitamins. Patients with morning sickness sometimes find it difficult. , 2006, Canadian family physician Medecin de famille canadien.

[9]  C. Stoll,et al.  Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. , 2006, Birth defects research. Part A, Clinical and molecular teratology.

[10]  Young-In Kim.  Does a high folate intake increase the risk of breast cancer? , 2006, Nutrition reviews.

[11]  G. Oakley,et al.  Tracking the prevention of folic acid-preventable spina bifida and anencephaly. , 2006, Birth defects research. Part A, Clinical and molecular teratology.

[12]  M. Cleves,et al.  Hospitalizations of Newborns With Folate-Sensitive Birth Defects Before and After Fortification of Foods With Folic Acid , 2006, Pediatrics.

[13]  T. Einarson,et al.  Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. , 2006, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[14]  G. Steinman.  Can the chance of having twins be modified by diet? , 2006, The Lancet.

[15]  P. Haggarty,et al.  Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study , 2006, The Lancet.

[16]  R. Zimmermann,et al.  Folic acid: a public-health challenge , 2006, The Lancet.

[17]  O. Devine,et al.  Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. , 2005, Birth defects research. Part A, Clinical and molecular teratology.

[18]  E. Castilla,et al.  Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile , 2005, American journal of medical genetics. Part A.

[19]  M. Cleves,et al.  Randomized trial of a physician-based intervention to increase the use of folic acid supplements among women. , 2005, American journal of obstetrics and gynecology.

[20]  S. Wen,et al.  A survey of preconceptional folic acid use in a group of Canadian women. , 2005, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[21]  L. Holmes,et al.  Trends in Congenital Malformations, 1974–1999: Effect of Prenatal Diagnosis and Elective Termination , 2004, Obstetrics and gynecology.

[22]  G. Oakley,et al.  Recommendations for accelerating global action to prevent folic acid-preventable birth defects and other folate-deficiency diseases: meeting of experts on preventing folic acid-preventable neural tube defects. , 2004, Birth defects research. Part A, Clinical and molecular teratology.

[23]  M. Levin,et al.  The relationship between serum cobalamin concentration and mean red cell volume at varying concentrations of serum folate. , 2004, Clinical and laboratory haematology.

[24]  A. Czeizel,et al.  Periconceptional folic acid/multivitamin supplementation and twin pregnancy. , 2004, American journal of obstetrics and gynecology.

[25]  J. Mills,et al.  Folic acid and the prevention of neural-tube defects. , 2004, The New England journal of medicine.

[26]  G. Koren,et al.  Multivitamin supplements for pregnant women. New insights. , 2004, Canadian family physician Medecin de famille canadien.

[27]  M. Cleves,et al.  Folic Acid Use by Women Receiving Routine Gynecologic Care , 2004, Obstetrics and gynecology.

[28]  J. Erickson,et al.  Vitamin supplements and the risk for congenital anomalies other than neural tube defects , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.

[29]  A. Czeizel,et al.  Periconceptional Multivitamin Supplementation and Multimalformed Offspring , 2003, Obstetrics and gynecology.

[30]  D. Young,et al.  The use of folic acid for the prevention of neural tube defects and other congenital anomalies. , 2003, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[31]  G. Oakley.  Folate deficiency is an "imminent health hazard" causing a worldwide birth defects epidemic. , 2003, Birth defects research. Part A, Clinical and molecular teratology.

[32]  M. Walker,et al.  The prevention of congenital anomalies with periconceptional folic acid supplementation. , 2003, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[33]  D. Cole,et al.  Association of neural tube defects and folic acid food fortification in Canada , 2002, The Lancet.

[34]  A. Olshan,et al.  Maternal Vitamin Use and Reduced Risk of Neuroblastoma , 2002, Epidemiology.

[35]  D. Economides,et al.  Neural tube defects and periconceptional folic acid. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[36]  E. Gucciardi,et al.  Incidence of neural tube defects in Ontario, 1986-1999. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[37]  M. C. Van den Hof,et al.  Incidence of open neural tube defects in Nova Scotia after folic acid fortification. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[38]  L. Abramsky,et al.  Effects of folic acid , 2002, The Lancet.

[39]  R. Rizzoli,et al.  Long-term increase in bone mass through high calcium intake before puberty , 2002, The Lancet.

[40]  J. Hobbins,et al.  Sonography of fetal cerebrospinal anomalies , 2002, Prenatal diagnosis.

[41]  M. Law,et al.  Quantifying the effect of folic acid , 2001, The Lancet.

[42]  R. Ball,et al.  Prevalence of aneuploidy and additional anatomic abnormalities in fetuses with open spina bifida: population based study in Utah. , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[43]  Judith G Hall,et al.  Folic acid: the opportunity that still exists , 2000 .

[44]  Hong Wang,et al.  Correction: Prevention of Neural-Tube Defects with Folic Acid in China. , 1999, The New England journal of medicine.

[45]  M. Khoury,et al.  Neural-tube defects. , 1999, The New England journal of medicine.

[46]  C. Levitt.  Canadian Perinatal Surveillance System. , 1998, Canadian family physician Medecin de famille canadien.

[47]  D. Jacobs,et al.  Predictors of red cell folate level in women attempting pregnancy. , 1997, JAMA.

[48]  M. Khoury,et al.  Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. , 1996, Pediatrics.

[49]  K. Jones,et al.  Smith's Recognizable Patterns of Human Malformation , 1996 .

[50]  W. Willett,et al.  Case-control study of periconceptional folic acid supplementation and oral clefts. , 1996, American journal of epidemiology.

[51]  M. Tolarová,et al.  Reduced Recurrence of Orofacial Clefts After Periconceptional Supplementation with High-Dose Folic Acid and Multivitamins , 1996 .

[52]  A. Czeizel.  Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. , 1996, American journal of medical genetics.

[53]  G. Shaw,et al.  Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. , 1995, American journal of medical genetics.

[54]  G. Shaw,et al.  Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally , 1995, The Lancet.

[55]  N. Weiss,et al.  PERICONCEPTIONAL MULTIVITAMIN USE IN RELATION TO THE RISK OF CONGENITAL URINARY TRACT ANOMALIES , 1995, Epidemiology.

[56]  D. Boomsma,et al.  Breastfeeding and neurological status , 1995, The Lancet.

[57]  J. Popkin,et al.  Neural tube defects in British Columbia , 1994, The Lancet.

[58]  J. Allanson,et al.  Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists. , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[59]  A. Czeizel.  Prevention of congenital abnormalities by periconceptional multivitamin supplementation. , 1993, BMJ.

[60]  M. J. Seller,et al.  Epidemiology and Control of Neural Tube Defects , 1993 .

[61]  A. Czeizel,et al.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. , 1992, The New England journal of medicine.

[62]  J. Boisvert,et al.  Prenatal diagnosis of fetal anomalies during the second trimester of pregnancy: Their characterization and delineation of defects in pregnancies at risk , 1991, Prenatal diagnosis.

[63]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[64]  F. Rosa,et al.  Spina bifida in infants of women treated with carbamazepine during pregnancy. , 1991, The New England journal of medicine.

[65]  K J Rothman,et al.  Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. , 1989, JAMA.

[66]  H. Hoffman,et al.  The absence of a relation between the periconceptional use of vitamins and neural-tube defects. National Institute of Child Health and Human Development Neural Tube Defects Study Group. , 1989, The New England journal of medicine.

[67]  F. Stanley,et al.  Dietary folate as a risk factor for neural‐tube defects: evidence from a case‐control study in Western Australia , 1989, The Medical journal of Australia.

[68]  R. Berry,et al.  Periconceptional use of multivitamins and the occurrence of neural tube defects. , 1989, JAMA.

[69]  F. Bieber,et al.  Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. , 1988, The New England journal of medicine.

[70]  F. Fraser,et al.  Epidemiological studies of neural tube defects in Newfoundland. , 1987, Teratology.

[71]  Lammer Ej,et al.  Teratogen update: valproic acid. , 1987, Teratology.

[72]  G. Ducharme,et al.  Date of conception and prevention of neural tube defects , 1984, Clinical genetics.

[73]  A. Hunter,et al.  Neural tube defects in Eastern Ontario and Western Quebec: demography and family data. , 1984, American journal of medical genetics.

[74]  P. Baird.  Neural tube defects in the Sikhs. , 1983, American journal of medical genetics.

[75]  J D Erickson,et al.  Etiologic heterogeneity of neural tube defects: clues from epidemiology. , 1982, American journal of epidemiology.

[76]  J. Warkany.  Aminopterin and methotrexate: folic acid deficiency. , 1978, Teratology.

[77]  P. Baird,et al.  Congenital anomalies of the central nervous system incidence in British Columbia, 1952-72. , 1978, Teratology.

[78]  L B Holmes,et al.  Etiologic heterogeneity of neural-tube defects. , 1976, The New England journal of medicine.

[79]  J. Pritchard.  HEMATOLOGIC ASPECTS OF PREGNANCY , 1960 .

[80]  J. Stockman.  Reduction in Neural-Tube Defects after Folic Acid Fortification in Canada , 2009 .

[81]  G. Oakley,et al.  Update on prevention of folic acid-preventable spina bifida and anencephaly. , 2009, Birth defects research. Part A, Clinical and molecular teratology.

[82]  M. Honein,et al.  Reduction in orofacial clefts following folic acid fortification of the U.S. grain supply. , 2007, Birth defects research. Part A, Clinical and molecular teratology.

[83]  Paige L. Williams,et al.  Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. , 2007, Birth defects research. Part A, Clinical and molecular teratology.

[84]  G. Koren,et al.  Study on circadian variation in folate pharmacokinetics. , 2005, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[85]  B. Chodirker.  Canadian Guidelines for Prenatal Diagnosis TECHNIQUES OF PRENATAL DIAGNOSIS , 2001 .

[86]  J. Hall.  Folic acid: the opportunity that still exists; [comment]. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[87]  T. Bui,et al.  Textbook of fetal ultrasound , 1999 .

[88]  A. Lalonde.  SOGC CLINICAL PRACTICE GUIDELINES , 1995 .

[89]  T. Ferris,et al.  Medical complications during pregnancy , 1982 .

[90]  M. McBride.  Sib risk of anencephaly and spina bifida in British Columbia. , 1979, American journal of medical genetics.